# FDA 483 - ARUP Laboratories Inc. - March 11, 2026

Source: https://www.globalkeysolutions.net/records/483/arup-laboratories-inc/c9819d9b-6361-4926-8697-d10623cdfae8

> FDA 483 for ARUP Laboratories Inc. on March 11, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: ARUP Laboratories Inc.
- Inspection Date: 2026-03-11
- Product Type: biologics
- Office Name: Denver District Office
- Summary: ARUP Laboratories, Inc. in Salt Lake City, Utah, a hospital transfusion service, received a Form 483 with five observations. The inspection revealed issues with recordkeeping for emergency transfusions, failure to follow and establish adequate standard operating procedures for blood product processing and storage, and deficiencies in facility temperature control for platelet handling. These observations indicate significant concerns regarding quality control and adherence to established protocols in blood product management.

## Related Officers

- [Emily Canire, CSO](https://www.globalkeysolutions.net/people/emily-canire-cso/718ae55d-9c6a-4e8d-8df1-c1634a693d27)
- [Manager, Data Science and Engineering](https://www.globalkeysolutions.net/people/kelly-d-moore/a5778f12-e968-4fc9-8391-b2cb5753232a)

Company: https://www.globalkeysolutions.net/companies/arup-laboratories-inc/07a582c1-c616-4043-9920-f8364839a568

Office: https://www.globalkeysolutions.net/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face